Quantifying the Impact of Bacterial Vaccines Against Antibiotic Resistance

Bacterial vaccines can significantly reduce antibiotic resistance by limiting bacterial transmission and colonization, but their impact depends on the vaccine mechanism of action.

The rise of antibiotic resistance (ABR) is a pressing global health concern. While developing bacterial vaccines is essential, anticipating their potential impact on ABR is essential. In this article, we'll explore into the findings of a recent study that explores the impact of bacterial vaccines on ABR through a mathematical model.

The Role of Vaccines in Combating Antibiotic Resistance

Vaccines have the potential to reduce bacterial infection, transmission, and colonization, making them a promising investment against ABR. By limiting the spread of bacteria, vaccines can help to reduce the selection pressure for antibiotic-resistant strains. However, the impact of vaccines on ABR depends on various factors, including the vaccine mechanism of action, the bacterial pathogen, and the level of coverage.

Compartmental Model and Mathematical Analysis

The study developed a compartmental model that formalized inter-individual transmission and selection pressure through both bystander and targeted antibiotic exposure. The model was used to simulate the impact of different vaccines on two bacterial types: Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli). The simulations showed that vaccines consistently reduced infection incidence, although to varying extents.

Vaccine Impact on S. aureus and E. coli

For S. aureus, a vaccine reducing acquisition rate, infection rate, and colonization duration by 60% at 70% coverage reduced total infections by 80%. In contrast, the same vaccine reduced total infections by only 48% for E. coli. The impact on the resistance proportion among colonized individuals differed markedly: this same vaccine increased it by 11% for S. aureus, while decreasing it by 8% for E. coli.

1. Vaccine mechanism of action matters: The impact of vaccines on ABR depends on the vaccine mechanism of action.
2. Bacterial type affects vaccine impact: The impact of vaccines on S. aureus and E. coli differed significantly.
3. Coverage level influences vaccine effectiveness: Higher coverage levels can lead to greater reductions in infection incidence.

Implications for Public Health Policy